FDA Inspection 1279816 — Cis Bio International
The FDA completed an inspection of Cis Bio International on January 26, 2024 in Saclay. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 26, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Saclay (France)
Additional Details
Mutual Recognition Agreement (MRA)